The global demand for Antithrombin Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
Antithrombin acts as a natural blood thinner or as an anticoagulant, is a protien present in human blood. The occurrence of antithrombin in the blood stream is very critical as it supports to prevent clotting of blood. There are two types of antithrombin deficiencies, called, type I and type II. Insufficient amount of antithrombin is called type I and type II is related with normal levels of antithrombin but reduced activity levels in case of affected patients’ blood. Blood clotting is associated with symptoms such as fainting, swollen legs or feet, increased heart rate, shortness of breath, among others.
The rising incidence of such conditions like sepsis, congenital antithrombin deficiency, disseminated intravascular coagulation (DIC), extracorporeal membrane oxygenation (ECMO), and elevated open-heart surgeries are likely to upsurge the growth of the market. Thrombotic diseases need a long term treatment; this support to the increase in sales of antithrombin. The increased usage of rapid diagnostic tests, which in turn use antithrombin, lifts the demand of the protein in the diagnostic field. However, high cost of antithrombin is hampering the market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of antithrombin.
The entire antithrombin market has been sub-categorized into dosage form, application, and source. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Dosage Form
This section covers regional segmentation which accentuates on current and future demand for antithrombin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Antithrombin Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the antithrombin market include rEVO Biologics Inc., Grifols, Shire plc., CSL Limited, Kedrion S.p.A., Lee Biosolutions, and Scripps Laboratories Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.